Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

COVID-19 coronavirus burnout depression pandemic

‘Not just a respiratory illness’: New stroke data highlight the importance of COVID-19 vaccinations

COVID-19 carries a higher stroke risk than similar infectious conditions, the authors explained, making it especially important to seek out a vaccine as soon as possible.

Thumbnail

Adding icosapent ethyl to statin therapy may reduce risk of stroke by 36%

Icosapent ethyl is an FDA-approved medication typically prescribed to limit triglycerides in the blood.

Several countries pause use of AstraZeneca COVID-19 vaccine due to blood clot concerns—US still sitting on millions of doses

While countries around the world have shared concerns, the World Health Organization and European Medicines Agency both still support the use of the vaccine. 

Thumbnail

Plant-based diets associated with a lower risk of stroke—but not if they are full of junk food

Eating a healthy plant-based diet—meaning a diet high in plant-based foods, not necessarily one that is exclusively plant-based—has been linked with lowering a person’s overall stroke risk by up to 10%.

Thumbnail

‘A cardiovascular problem disguised as an eye problem’: Why CRAO requires immediate treatment

These strokes are a "critical sign of ill health" and are often followed by other serious vascular issues, a group of specialists warned. 

Thumbnail

Beta-blockers, ACE inhibitors, ARBs lead to improved long-term outcomes for aortic dissection patients

The study's authors tracked nearly 7,000 adult AD patients who were treated from 2001 to 2013.

Thumbnail

American Indians have an especially high risk of stroke, leaving researchers with many questions

The study included data from nearly 17 million adults who received treatment from 2005 to 2011. Researchers compared the stroke rates of patients with atrial fibrillation and those without it. 

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.